News

Former F.D.A. Chief Backs Kennedy’s War on Processed Food
Dr. David A. Kessler has outlined a legal path for Health Secretary Robert F. Kennedy Jr. to take on the food industry, while ...
Kennedy’s crusade against food safety rule threatens supplement industry
By going after an obscure regulatory designation he describes as a “loophole,” the health secretary has put an industry he ...
What is kratom 7-OH? Why RFK and health officials are cracking down
OH, a component of kratom, is an opioid that “can be more potent than morphine,” but it’s readily available over the counter ...
FDA Introduces ‘PreCheck’ Plan to Strengthen US Drug Facilities
The FDA Thursday announced a program that seeks to strengthen domestic drug manufacturing by increasing regulatory ...
MAXONA PHARMACEUTICALS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR MAX-001
MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...
US FDA approves Jazz Pharma's drug for rare brain tumor
The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...
The Food and Drug Administration (FDA) issued a nationwide recall over fears of steel in products
Anew food safety alert has put a common food in the spotlight in Latino households in the United States. The Food and Drug ...
Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug
The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to negotiations that could either lead to a new alliance or Arvinas to seek a new ...
Food Safety News13h
EFSA’s novel food review has the cell-cultured industry waiting in a ‘trough of disillusionment’
A year ago, applications for a cell-cultured foie gras product were dropped off at the United States Food and Drug ...
U.S. Drug Innovation and Deadly Diagnoses
The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...